Hiva Kolodrubetz, NP, provides an engaging and detailed session on anti-diabetic medications, focusing on safe prescribing and effective management strategies. Highlighting pharmacological mechanisms, A1C goals, and patient-centered care,…
Associate Professor Mike Todorovic, AKA “Dr. Mike”, introduces the endocrine system, explaining how hormones act as chemical messengers released into the bloodstream by cells, tissues, and glands. He…
NEW YORK (Reuters Health) – Random blood glucose (RBG) measurements early in pregnancy can identify women with overt diabetes in pregnancy (ODIP), researchers from UK report in the…
NEW YORK (Reuters Health) – A Danish study indicates that among patients undergoing percutaneous coronary intervention, the use of zotarolimus-eluting stents (ZESs) rather than sirolimus-eluting stents (SESs) is…
NEW YORK (Reuters Health) – The high risk of fractures in the first year after solid organ transplantation can be roughly halved with bisphosphonate or vitamin D treatment,…
NEW YORK (Reuters Health) – Vitamin D, especially in combination with calcium, may reduce the risk of falls, according to a report in the July 27th online issue…
NEW YORK (Reuters Health) – The presence of peripheral neuropathy, and not diabetes per se, increases the risk of surgical site infections after foot and ankle surgery, according…
NEW YORK (Reuters Health) – Intensive treatment of type 2 diabetes that’s detected early through screening does not seem to reduce rates of subsequent complications, a Danish study…
NEW YORK (Reuters Health) – Mitotane combined with fast-acting steroidogenesis inhibitors might avoid the need for emergency bilateral adrenalectomy in patients with severe hypercortisolism, French researchers report in…
NEW YORK (Reuters Health) – Most patients with differentiated thyroid cancer metastasized to bone benefit from iodine-131 therapy, with stabilization of disease and significant reduction in pain, a…
NEW YORK (Reuters Health) – A novel glucose-lowering drug, dapagliflozin, improves glycemic control in patients with type 2 diabetes already on metformin, and it promotes significant weight loss,…
NEW YORK (Reuters Health) – A 4-year placebo-controlled trial of alpha-lipoic acid to treat diabetes-related polyneuropathy produced no improvement in the study’s composite endpoint, but there were clinically…
